Preferential interaction between the dopamine D2 receptor and arrestin2 in neostriatal neurons

Molecular Pharmacology

Volumn 66, Issue 6, 2004, Pages 1635-1642

  Macey, Tara A ^a   Gurevich, Vsevolod V ^b   Neve, Kim A ^a  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; ARRESTIN 2; BUTACLAMOL; DOPAMINE 2 RECEPTOR; GREEN FLUORESCENT PROTEIN; HALOPERIDOL; RETINA S ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; DRUG RECEPTOR BINDING; INTERNALIZATION; MOLECULAR INTERACTION; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ANIMALS; ARRESTINS; BIOTINYLATION; CELL LINE; CELLS, CULTURED; MALE; NEOSTRIATUM; NEURONS; PHOSPHOPROTEINS; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 9444280897     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.001495     Document Type: Article

References (34)

1. 2 dopamine receptors in human Y-79 retinoblastomal cells. Mol Pharmacol 39:650-658.
2. Bennett TA, Maestas DC, and Prossnitz ER (2000) Arrestin binding to the G protein-coupled N-formyl peptide receptor is regulated by the conserved "DRY" sequence. J Biol Chem 275:24590-24594.
3. L receptor in human embryonic kidney 293 cells. Mol Pharmacol 48:956-964.
4. Cen B, Xiong Y, Ma L, and Pei G (2001) Direct and differential interaction of β-arrestins with the intracellular domains of different opioid receptors. Mol Pharmacol 59:758-764.
5. Chio CL, Lajiness ME, and Huff RM (1994) Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors. Mol Pharmacol 45:51-60.
6. 2-adrenergic receptors determines subtype specificity of arrestin interaction. J Biol Chem 277:43247-43252.
7. 2A receptor: The third intracellular loop is α-helical and binds purified arresting. J Neurochem 72:2206-2214.
8. Gurevich EV, Benovic JL, and Gurevich W (2002) Arrestin2 and arrestin3 are differentially expressed in the rat brain during postnatal development. Neuroscience 109:421-436.
9. Gurevich W and Gurevich EV (2004) The molecular acrobatics of arrestin activation. Trends Pharmacol Sci 25:105-111.
10. Han M, Gurevich VV, Vishnivetskiy SA, Sigler PB, and Schubert C (2001) Crystal structure of β-arrestin at 1.9 Å: possible mechanism of receptor binding and membrane translocation. Structure (Camb) 9:869-880.
11. Hüttenrauch F, Nitzki A, Lin FT, Höning S, and Oppermann M (2002) β-arrestin binding to CC chemokine receptor 5 requires multiple C-terminal receptor phosphorylation sites and involves a conserved Asp-Arg-Tyr sequence motif. J Biol Chem 277:30769-30777.
12. Ito K, Haga T, Lameh J, and Sadée W (1999) Sequestration of dopamine D2 receptors depends on coexpression of G-protein-coupled receptor kinases 2 or 5. Eur J Biochem 260:112-119.
13. 2 receptors expressed in Chinese hamster ovary cells. Mol Pharmacol 49:560-566.
14. 3 receptors by G protein-coupled receptor kinases and β-arrestins. J Biol Chem 276:37409-37414.
15. Kim SJ, Kim MY, Lee EJ, Ahn YS, and Baik JH (2004) Distinct regulation of internalization and mitogen-activated protein kinase activation by two isoforms of the dopamine D2 receptor. Mol Endocrinol 18:640-652.
16. Krupnick JG and Benovic JL (1998) The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 38:289-319.
17. Krupnick JG, Gurevich VV, Schepers T, Hamm HE, and Benovic JL (1994) Arrestin-rhodopsin interaction. Multi-site binding delineated by peptide inhibition. J Biol Chem 268:3226-3232.
18. Luttrell LM, Roudabush FL, Choy EW, Miller WE, Field ME, Pierce KL, and Lefkowitz RJ (2001) Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds. Proc Natl Acad Sci USA 88:2449-2454.
19. Mukherjee S, Gurevich W, Preninger A, Hamm HE, Bader MF, Fazleabas AT, Birnbaumer L, and Hunzicker-Dunn M (2002) Aspartic acid 564 in the third cytoplasmic loop of the luteinizing hormone/choriogonadotropin receptor is crucial for phosphorylation-independent interaction with arrestin2. J Biol Chem 277: 17916-17927.
20. Mukherjee S, Palczewski K, Gurevich VV, and Hunzicker-Dunn M (1999) β-Arrestin-dependent desensitization of luteinizing hormone/ choriogonadotropin receptor is prevented by a synthetic peptide corresponding to the third intracellular loop of the receptor. J Biol Chem 274:12984-12989.
21. Nakamura K, Liu XB, and Ascoli M (2000) Seven non-contiguous intracellular residues of the lutropin/choriogonadotropin receptor dictate the rate of agonist-induced internalization and its sensitivity to non-visual arrestins. J Biol Chem 275:241-247.
22. Neve KA, Cox BA, Henningsen RA, Spanoyannis A, and Neve RL (1991) Pivotal role for aspartate-80 in the regulation of D2 receptor affinity for drugs and inhibition of adenylyl cyclase. Mol Pharmacol 39:733-739.
23. L receptor to desensitization accompanies the up-regulation of receptors on to the surface of Sf9 cells. Endocrinology 138:4199-4206.
24. Oakley RH, Laporte SK, Holt JA, Caron MG, and Barak LS (2000) Differential affinities of visual arrestin, βarrestin1 and βarrestin2 for G protein-coupled receptors delineate two major classes of receptors. J Biol Chem 275:17201-17210.
25. 2-adrenergic receptors permit receptor resensitization. Mol Pharmacol 47:666-676.
26. Raraan D, Osawa S, and Weiss ER (1999) Binding of arrestin to cytoplasmic loop mutants of bovine rhodopsin. Biochemistry 38:5117-5123.
27. Shenoy SK and Lefkowitz RJ (2003) Trafficking patterns of β-arrestin and G protein-coupled receptors determined by the kinetics of β-arrestin deubiquitination. J Biol Chem 278:14498-14506.
28. 2-adrenergic receptors. J Biol Chem 275:29082-29090.
29. Sibley DR and Neve KA (1997) Regulation of dopamine receptor function and expression, in The Dopamine Receptors (Neve KA and Neve RL eds) pp 383-424, Humana Press, Totowa, NJ.
30. Tsao P, Cao T, and von Zastrow M (2001) Role of endocytosis in mediating down-regulation of G-protein-coupled receptors. Trends Pharmacol Sci 22:91-96.
31. Tulipano G, Stumm R, Pfeiffer M, Kreienkamp HJ, Hüllt V, and Schulz S (2004) Differential β-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes. J Biol Chem 279:21374-21382.
32. Vickery RG and von Zastrow M (1999) Distinct dynamin-dependent and -independent mechanisms target structurally homologous dopamine receptors to different endocytic membranes. J Cell Biol 144:31-43.
33. 2- adrenergic receptors. J Biol Chem 272:17836-17842.
34. 2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells. Mol Pharmacol 45;878-889.